Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples.
暂无分享,去创建一个
Matthias Egger | G. Rutherford | M. Egger | A. Anglemyer | N. Siegfried | Andrew Anglemyer | Nandi Siegfried | George W Rutherford
[1] T. Hallett,et al. Estimating the risk of HIV transmission from homosexual men receiving treatment to their HIV-uninfected partners , 2010, Sexually Transmitted Infections.
[2] W. Miller,et al. Role of acute and early HIV infection in the sexual transmission of HIV , 2010, Current opinion in HIV and AIDS.
[3] Robert M Grant,et al. Antiretroviral agents used by HIV-uninfected persons for prevention: pre- and postexposure prophylaxis. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] E. Karita,et al. New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: an analysis of survey and clinical data , 2008, The Lancet.
[5] A. Lazzarin,et al. Antiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Italian Study Group on HIV Heterosexual Transmission. , 1994 .
[6] T. Flanigan,et al. Sex-Associated Differences in Pre-Antiretroviral Therapy Plasma HIV-1 RNA in Diverse Areas of the World Vary by CD4+ T-Cell Count , 2011, Antiviral therapy.
[7] G. Lorello,et al. Discordance in HIV‐1 viral loads and antiretroviral drug concentrations comparing semen and blood plasma , 2009, HIV medicine.
[8] Jeffrey N. Martin,et al. Decline in HIV infectivity following the introduction of highly active antiretroviral therapy , 2003, AIDS.
[9] G. Rutherford,et al. Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples. , 2013, The Cochrane database of systematic reviews.
[10] J. Castilla,et al. Effectiveness of Highly Active Antiretroviral Therapy in Reducing Heterosexual Transmission of HIV , 2005, Journal of acquired immune deficiency syndromes.
[11] Christopher Dye,et al. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model , 2009, The Lancet.
[12] Douglas G Altman,et al. Interaction revisited: the difference between two estimates , 2003, BMJ : British Medical Journal.
[13] J. P. Ekwaru,et al. Risk factors for recent HIV infection in Uganda. , 2008, JAMA.
[14] O. Uthman,et al. Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals. , 2012, The Cochrane database of systematic reviews.
[15] Joep Lange,et al. The spread, treatment, and prevention of HIV-1: evolution of a global pandemic. , 2008, The Journal of clinical investigation.
[16] Evan Wood,et al. Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study , 2009, BMJ : British Medical Journal.
[17] S. Twu,et al. Decreased HIV transmission after a policy of providing free access to highly active antiretroviral therapy in Taiwan. , 2004, The Journal of infectious diseases.
[18] Fanelo James Arens,et al. Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure. , 2007, The Cochrane database of systematic reviews.
[19] Ivana S Varella,et al. Sexual Transmission of HIV-1 Among Serodiscordant Couples in Porto Alegre, Southern Brazil , 2008, Sexually transmitted diseases.
[20] Myron S Cohen,et al. Treatment to prevent transmission of HIV-1. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] G. Rutherford,et al. Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda , 2006, AIDS.
[22] Yiming Shao,et al. Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003–11): a national observational cohort study , 2013, The Lancet.
[23] M. Schechter,et al. Genital HIV-1 viral load is correlated with blood plasma HIV-1 viral load in Brazilian women and is reduced by antiretroviral therapy. , 2006, The Journal of infection.
[24] David V Glidden,et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. , 2010, The New England journal of medicine.
[25] S. Blower,et al. Narrative Review: Antiretroviral Therapy to Prevent the Sexual Transmission of HIV-1 , 2007, Annals of Internal Medicine.
[26] Peter Brocklehurst,et al. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. , 2011, The Cochrane database of systematic reviews.
[27] P. Harrigan,et al. Improved virological outcomes in British Columbia concomitant with decreasing incidence of HIV type 1 drug resistance detection. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[28] R. Kaul,et al. Persistent HIV RNA shedding in semen despite effective antiretroviral therapy , 2009, AIDS.
[29] Michael Rayment,et al. Prevention of HIV-1 infection with early antiretroviral therapy , 2012, Journal of Family Planning and Reproductive Health Care.
[30] D. Stram,et al. Role of viral load in heterosexual transmission of human immunodeficiency virus type 1 by blood transfusion recipients. Transfusion Safety Study Group. , 1997, American journal of epidemiology.
[31] G. Guyatt,et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations , 2008, BMJ : British Medical Journal.
[32] A. Lazzarin,et al. Antiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Italian Study Group on HIV Heterosexual Transmission. , 1994, Archives of internal medicine.
[33] V. Robison,et al. Male Viral Load and Heterosexual Transmission of HIV‐1 Subtype E in Northern Thailand , 2002, Journal of acquired immune deficiency syndromes.
[34] Matthias Egger,et al. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis , 2009, AIDS.
[35] S. Vermund,et al. Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa. , 2001, AIDS research and human retroviruses.
[36] Michele Tarsilla. Cochrane Handbook for Systematic Reviews of Interventions , 2010, Journal of MultiDisciplinary Evaluation.
[37] P. Peters,et al. Modified Kigali combined staging predicts risk of mortality in HIV-infected adults in Lusaka, Zambia. , 2008, AIDS research and human retroviruses.
[38] Evan Wood,et al. Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study , 2010, The Lancet.
[39] E. Vittinghoff,et al. Decreases in Community Viral Load Are Accompanied by Reductions in New HIV Infections in San Francisco , 2010, PloS one.
[40] T. Quinn,et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. , 2000, The New England journal of medicine.
[41] Connie Celum,et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis , 2010, The Lancet.
[42] Ronald H Gray,et al. HIV-1 transmission among HIV-1 discordant couples before and after the introduction of antiretroviral therapy , 2011, AIDS.
[43] J. Baeten,et al. Male circumcision and risk of male-to-female HIV-1 transmission: a multinational prospective study in African HIV-1-serodiscordant couples , 2010, AIDS.